284 related articles for article (PubMed ID: 3518963)
61. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
[TBL] [Abstract][Full Text] [Related]
62. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.
von Graevenitz A; Bucher C
Infection; 1982; 10(5):293-8. PubMed ID: 6293976
[TBL] [Abstract][Full Text] [Related]
63. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
Rylander M; Brorson JE; Johnsson J; Norrby R
Antimicrob Agents Chemother; 1979 Apr; 15(4):572-9. PubMed ID: 464588
[TBL] [Abstract][Full Text] [Related]
64. [In vitro antibacterial activity of new oxime type of beta-lactam antibiotics].
Holá V; Adensamová J; Mandel M
Cesk Farm; 1990 Sep; 39(7):302-4. PubMed ID: 2098202
[TBL] [Abstract][Full Text] [Related]
65. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
Infection; 1983; 11(6):315-7. PubMed ID: 6321357
[TBL] [Abstract][Full Text] [Related]
66. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
[TBL] [Abstract][Full Text] [Related]
67. In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.
Skalova R; Hajsig D; Muic V; Kapun D
Infection; 1980; 8 Suppl 3():S 330-3. PubMed ID: 6447672
[TBL] [Abstract][Full Text] [Related]
68. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams.
Dajani AS; Pokowski LH
Scand J Infect Dis Suppl; 1990; 73():31-42. PubMed ID: 2091255
[TBL] [Abstract][Full Text] [Related]
69. The in vitro activity of ceftazidime against resistant clinical isolates.
Van Landuyt HW; Denolf BL; Pyckavet M; Lambert AM
Infection; 1983; 11 Suppl 1():S23-7. PubMed ID: 6299967
[TBL] [Abstract][Full Text] [Related]
70. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
Saionji K
Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
[TBL] [Abstract][Full Text] [Related]
71. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
Jones RN; Pfaller MA; Allen SD; Gerlach EH; Fuchs PC; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(4):361-4. PubMed ID: 1889187
[TBL] [Abstract][Full Text] [Related]
72. In vitro evaluation of cefoxitin and cefamandole.
Adams HG; Stilwell GA; Turck M
Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
[TBL] [Abstract][Full Text] [Related]
73. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
[TBL] [Abstract][Full Text] [Related]
74. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
[TBL] [Abstract][Full Text] [Related]
75. A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Amyes SG; Baird DR; Crook DW; Gillespie SH; Howard AJ; Oppenhiem BA; Pedler SJ; Paull A; Tompkins DS; Lawrie SA
J Antimicrob Chemother; 1994 Nov; 34(5):639-48. PubMed ID: 7706159
[TBL] [Abstract][Full Text] [Related]
76. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
Morel C; Vergnaud M; Langeard MM; Dupuy L
J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
[TBL] [Abstract][Full Text] [Related]
77. Role of new cephamycins in the management of obstetric and gynecologic infections.
Jones RN
J Reprod Med; 1990 Nov; 35(11 Suppl):1070-7. PubMed ID: 2277375
[TBL] [Abstract][Full Text] [Related]
78. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
Svarva PL; Lyng RV; Maeland JA
Scand J Infect Dis; 1985; 17(4):387-91. PubMed ID: 3911375
[TBL] [Abstract][Full Text] [Related]
79. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
Randolph JA; Buck RE; Price KE; Leitner F
J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
[TBL] [Abstract][Full Text] [Related]
80. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
Obaseiki-Ebor EE; Afonya TC; Oyaide SM
Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
